Back to all bills
S 535119th CongressIntroduced
Respect Parents’ Childcare Choices Act
Introduced: Oct 29, 2025
Standard Summary
Comprehensive overview in 1-2 paragraphs
The Combating Illicit Xylazine Act places xylazine in Schedule III of the Controlled Substances Act with transition periods for compliance and reporting requirements.
Key Points
- 1Schedules xylazine in Schedule III of the Controlled Substances Act
- 2Defines specific authorized uses for veterinary purposes only
- 3Provides 60-day transition period for practitioner registration requirements
- 4Provides 1-year transition period for labeling and packaging requirements
- 5Exempts ultimate users from registration requirements for legitimate veterinary use
- 6Requires ARCOS tracking and sentencing commission guidelines review
- 7Mandates reports to Congress on xylazine prevalence and trafficking
Impact Areas
Veterinary medicineDrug enforcement agenciesSubstance abuse treatmentPharmaceutical industryCriminal justice systemPublic health
Generated by kwaipilot/kat-coder-pro:free on Nov 19, 2025